Enoxaparin and antifactor Xa levels in acute burn patients.

@article{Lin2011EnoxaparinAA,
  title={Enoxaparin and antifactor Xa levels in acute burn patients.},
  author={Hsin Chiung Lin and Iris H Faraklas and Amalia Cochran and J. R. Saffle},
  journal={Journal of burn care & research : official publication of the American Burn Association},
  year={2011},
  volume={32 1},
  pages={1-5}
}
Altered pharmacokinetics in critically ill patients have been shown to result in inadequate enoxaparin dosing for venous thromboembolism (VTE) prophylaxis. In the burn unit, routine monitoring of antifactor Xa levels was implemented to ensure adequate VTE prophylaxis. The purpose of this study was to examine the appropriateness of enoxaparin dosing for VTE prophylaxis in this specialized patient population. The authors reviewed patients with acute burn injury from June 1, 2009, to October 20… CONTINUE READING